Company Products Research Collaborators Regulatory Investor Relations Contact Us  

The formation of Nuovo Biologics represents several years of research and development exploring new broad spectrum antiviral, as well as oncology, technologies. Founded in 2010 and based in Florida, the Company is commercializing an innovative set of protein drugs. Our first drug formulation is “PVX”, which appears to treat a broad spectrum of viral infections, including those caused by herpes, influenza, and particular retroviruses; another, “MMX”, for specific malignant tumors. Both drugs are expected to be effective across animal species, and possibly, in humans.

Kelly, dumped by her owners, overcomes distemper, lands in loving home: People and their pets
Nuovo Biologics partnered with a local Ohio organization to offer life-saving treatment to an abandoned dog suffering from Distemper. Read More

Auburn University and Nuovo Biologics Announce Academic-Biotech Collaboration

Researchers from Auburn University's Research Initiative in Cancer (AURIC), and Nuovo Biologics LLC, of Davie, Fl., have announced a partnership to develop new therapies for cancer. Read More

Click here for more news updates!
One Health Philosophy Antiviral